Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of brain natriuretic peptide in population screening.

Literature DB >> 14574056

The role of brain natriuretic peptide in population screening.

Liselotte N Dyrbye¹, Margaret M Redfield.

Abstract

While measurement of plasma BNP concentration has been shown to be useful in the diagnosis of heart failure, its role as a screening test for detection of pre-clinical ventricular remodeling or dysfunction in the general population has not been established. Here we review available population-based studies assessing the predictive characteristics of BNP for the detection of pre-clinical structural heart disease (Stage B Heart Failure).

Entities: Disease Gene

Mesh：

Substances：

Year: 2003 PMID： 14574056 DOI： 10.1023/a:1026143231117

Source DB: PubMed Journal: Heart Fail Rev ISSN： 1382-4147 Impact factor: 4.214

42 in total

1. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

Authors: R S Vasan; M G Larson; E J Benjamin; J C Evans; D Levy
Journal: N Engl J Med Date: 1997-05-08 Impact factor: 91.245

2. The prevention of heart failure--a new agenda.

Authors: J N Cohn
Journal: N Engl J Med Date: 1992-09-03 Impact factor: 91.245

3. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors: S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal: N Engl J Med Date: 2000-01-20 Impact factor: 91.245

4. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.

Authors: T A McDonagh; C E Morrison; A Lawrence; I Ford; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal: Lancet Date: 1997-09-20 Impact factor: 79.321

5. Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey.

Authors: Donna K Arnett; Paul G McGovern; David R Jacobs; Eyal Shahar; Sue Duval; Henry Blackburn; Russell V Luepker
Journal: Am J Epidemiol Date: 2002-11-15 Impact factor: 4.897

Review 6. Preventive health services in adults.

Authors: H C Sox
Journal: N Engl J Med Date: 1994-06-02 Impact factor: 91.245

7. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population.

Authors: A Luchner; J C Burnett; M Jougasaki; H W Hense; I M Heid; F Muders; G A Riegger; H Schunkert
Journal: J Hypertens Date: 2000-08 Impact factor: 4.844

8. Biochemical detection of left-ventricular systolic dysfunction.

Authors: T A McDonagh; S D Robb; D R Murdoch; J J Morton; I Ford; C E Morrison; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal: Lancet Date: 1998-01-03 Impact factor: 79.321

9. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study.

Authors: R B Devereux; M J Roman; J E Liu; T K Welty; E T Lee; R Rodeheffer; R R Fabsitz; B V Howard
Journal: Am J Cardiol Date: 2000-11-15 Impact factor: 2.778

10. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

Authors: K Yamamoto; J C Burnett; M Jougasaki; R A Nishimura; K R Bailey; Y Saito; K Nakao; M M Redfield
Journal: Hypertension Date: 1996-12 Impact factor: 10.190

1 in total

1. Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010.

Authors: Shahram Shahangian; Todd D Alspach; J Rex Astles; Ajay Yesupriya; William K Dettwyler
Journal: Arch Pathol Lab Med Date: 2013-06-05 Impact factor: 5.534

1 in total